Terms: = Gastric cancer AND HRAS, K-ras, 3265, ENSG00000174775, HRAS1, RASH1, c-bas/has, P01112, N-ras
219 results:
1. Myotubularin-related-protein-7 inhibits mutant (G12V) k-ras by direct interaction.
Weidner P; Saar D; Söhn M; Schroeder T; Yu Y; Zöllner FG; Ponelies N; Zhou X; Zwicky A; Rohrbacher FN; Pattabiraman VR; Tanriver M; Bauer A; Ahmed H; Ametamey SM; Riffel P; Seger R; Bode JW; Wade RC; Ebert MPA; Kragelund BB; Burgermeister E
Cancer Lett; 2024 Apr; 588():216783. PubMed ID: 38462034
[TBL] [Abstract] [Full Text] [Related]
2. Characteristic Mutational Damages in gastric and Colorectal Adenocarcinomas.
Yermekova S; Orazgaliyeva M; Goncharova T; Rakhimbekova F; Kaidarova D; Shatkovskaya O
Asian Pac J Cancer Prev; 2023 Nov; 24(11):3939-3947. PubMed ID: 38019254
[TBL] [Abstract] [Full Text] [Related]
3. Exploring the mechanism of ellagic acid against gastric cancer based on bioinformatics analysis and network pharmacology.
Liu Z; Huang H; Yu Y; Li L; Shi X; Wang F
J Cell Mol Med; 2023 Dec; 27(23):3878-3896. PubMed ID: 37794689
[TBL] [Abstract] [Full Text] [Related]
4. Machine learning models predict the mTOR signal pathway-related signature in the gastric cancer involving 2063 samples of 7 centers.
Zhang H; Zhuo H; Hou J; Cai J
Aging (Albany NY); 2023 Jun; 15(13):6152-6162. PubMed ID: 37341987
[TBL] [Abstract] [Full Text] [Related]
5. hras overexpression predicts response to Lenvatinib treatment in gastroenteropancreatic neuroendocrine tumors.
Liverani C; Spadazzi C; Ibrahim T; Pieri F; Foca F; Calabrese C; De Vita A; Miserocchi G; Cocchi C; Vanni S; Ercolani G; Cavaliere D; Ranallo N; Chiadini E; Prisinzano G; Severi S; Sansovini M; Martinelli G; Bongiovanni A; Mercatali L
Front Endocrinol (Lausanne); 2022; 13():1045038. PubMed ID: 36743926
[TBL] [Abstract] [Full Text] [Related]
6. Bcl-2 and Noxa are potential prognostic indicators for patients with gastroenteropancreatic neuroendocrine neoplasms.
Guo Y; Zhang L; Zhang N; Chen L; Luo Q; Liu M; Yang D; Chen J
Endocrine; 2022 Oct; 78(1):159-168. PubMed ID: 35895181
[TBL] [Abstract] [Full Text] [Related]
7. Genetic variation of
Jin X; Dai M; Zhou Y
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2022 Jan; 47(1):101-108. PubMed ID: 35545369
[No Abstract] [Full Text] [Related]
8. Comprehensive Analysis of Large-Scale Transcriptomes from Multiple cancer Types.
Nong B; Guo M; Wang W; Songyang Z; Xiong Y
Genes (Basel); 2021 Nov; 12(12):. PubMed ID: 34946814
[TBL] [Abstract] [Full Text] [Related]
9. Determining oncogenic patterns and cancer predisposition through the transcriptomic profile in Mitchell-Riley syndrome with heterotopic gastric mucosa and duodenal atresia: a case report.
Calcaterra V; Chiricosta L; Mazzon E; Gugnandolo A; Alberti D; Maestri L; Meroni M; Vestri E; Verduci E; Dilillo D; Zuccotti G; Pelizzo G
Orphanet J Rare Dis; 2021 Oct; 16(1):455. PubMed ID: 34715892
[TBL] [Abstract] [Full Text] [Related]
10. Erianin, the main active ingredient of Dendrobium chrysotoxum Lindl, inhibits precancerous lesions of gastric cancer (PLGC) through suppression of the hras-PI3K-AKT signaling pathway as revealed by network pharmacology and in vitro experimental verification.
Wang Y; Chu F; Lin J; Li Y; Johnson N; Zhang J; Gai C; Su Z; Cheng H; Wang L; Ding X
J Ethnopharmacol; 2021 Oct; 279():114399. PubMed ID: 34246740
[TBL] [Abstract] [Full Text] [Related]
11. Study of the active ingredients and mechanism of Sparganii rhizoma in gastric cancer based on HPLC-Q-TOF-MS/MS and network pharmacology.
Lu X; Zheng Y; Wen F; Huang W; Chen X; Ruan S; Gu S; Hu Y; Teng Y; Shu P
Sci Rep; 2021 Jan; 11(1):1905. PubMed ID: 33479376
[TBL] [Abstract] [Full Text] [Related]
12. [Clinical analysis of 12 cases of acute myeloid leukemia complicated with synchronous primary solid tumor].
Mi RH; Dang HB; Chen L; Han YL; Wang MF; Zhang YL; Chen L; Li DB; Wei XD
Zhonghua Yi Xue Za Zhi; 2020 Nov; 100(42):3323-3327. PubMed ID: 33202495
[No Abstract] [Full Text] [Related]
13. A MXI1-NUTM1 fusion protein with MYC-like activity suggests a novel oncogenic mechanism in a subset of NUTM1-rearranged tumors.
McEvoy CR; Holliday H; Thio N; Mitchell C; Choong DY; Yellapu B; Leong HS; Xu H; Lade S; Browning J; Takano EA; Byrne DJ; Gill AJ; Duong CP; Li J; Fellowes AP; Fox SB; Swarbrick A; Prall OWJ
Lab Invest; 2021 Jan; 101(1):26-37. PubMed ID: 32873880
[TBL] [Abstract] [Full Text] [Related]
14. Clinicopathological and Molecular Differences Between gastric-type Mucinous Carcinoma and Usual-type Endocervical Adenocarcinoma of the Uterine Cervix.
Jung H; Bae GE; Kim HM; Kim HS
Cancer Genomics Proteomics; 2020; 17(5):627-641. PubMed ID: 32859641
[TBL] [Abstract] [Full Text] [Related]
15. RAS and RHO family GTPase mutations in cancer: twin sons of different mothers?
Hodge RG; Schaefer A; Howard SV; Der CJ
Crit Rev Biochem Mol Biol; 2020 Aug; 55(4):386-407. PubMed ID: 32838579
[TBL] [Abstract] [Full Text] [Related]
16. Impact of sex and age on chemotherapy efficacy, toxicity and survival in localised oesophagogastric cancer: A pooled analysis of 3265 individual patient data from four large randomised trials (OE02, OE05, MAGIC and ST03).
Athauda A; Nankivell M; Langley RE; Alderson D; Allum W; Grabsch HI; Starling N; Chau I; Cunningham D
Eur J Cancer; 2020 Sep; 137():45-56. PubMed ID: 32745964
[TBL] [Abstract] [Full Text] [Related]
17. Uptake and tumor-suppressive pathways of exosome-associated GKN1 protein in gastric epithelial cells.
Yoon JH; Ashktorab H; Smoot DT; Nam SW; Hur H; Park WS
Gastric Cancer; 2020 Sep; 23(5):848-862. PubMed ID: 32291710
[TBL] [Abstract] [Full Text] [Related]
18. [Clinicopathological characteristics, MSI and k-ras gene mutations of double primary malignancies associated with colorectal cancer].
Li Q; Zhang B; Niu FN; Ye Q; Chen J; Fan XS
Zhonghua Yi Xue Za Zhi; 2020 Feb; 100(4):301-306. PubMed ID: 32075360
[No Abstract] [Full Text] [Related]
19. GPR30-Expressing gastric Chief Cells Do Not Dedifferentiate But Are Eliminated via PDK-Dependent Cell Competition During Development of Metaplasia.
Hata M; Kinoshita H; Hayakawa Y; Konishi M; Tsuboi M; Oya Y; Kurokawa K; Hayata Y; Nakagawa H; Tateishi K; Fujiwara H; Hirata Y; Worthley DL; Muranishi Y; Furukawa T; Kon S; Tomita H; Wang TC; Koike K
Gastroenterology; 2020 May; 158(6):1650-1666.e15. PubMed ID: 32032583
[TBL] [Abstract] [Full Text] [Related]
20. Impact of bariatric surgery on cardiovascular outcomes and mortality: a population-based cohort study.
Singh P; Subramanian A; Adderley N; Gokhale K; Singhal R; Bellary S; Nirantharakumar K; Tahrani AA
Br J Surg; 2020 Mar; 107(4):432-442. PubMed ID: 31965568
[TBL] [Abstract] [Full Text] [Related]
[Next]
